0001628280-23-023651.txt : 20230627 0001628280-23-023651.hdr.sgml : 20230627 20230627184019 ACCESSION NUMBER: 0001628280-23-023651 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230623 FILED AS OF DATE: 20230627 DATE AS OF CHANGE: 20230627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blanks Robert CENTRAL INDEX KEY: 0001815433 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36485 FILM NUMBER: 231048800 MAIL ADDRESS: STREET 1: C/O ARDELYX STREET 2: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARDELYX, INC. CENTRAL INDEX KEY: 0001437402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 510-745-7047 MAIL ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: NTERYX INC DATE OF NAME CHANGE: 20080611 4 1 wk-form4_1687905603.xml FORM 4 X0407 4 2023-06-23 0 0001437402 ARDELYX, INC. ARDX 0001815433 Blanks Robert C/O ARDELYX, INC. 400 FIFTH AVENUE, SUITE 210 WALTHAM MA 02451 0 1 0 0 See Remarks 1 Common Stock 2023-06-23 4 M 0 33333 3.42 A 299467 D Common Stock 2023-06-23 4 S 0 33333 3.6313 D 266134 D Stock Option (Right to Buy) 3.42 2023-06-23 4 M 0 33333 0 D 2014-07-18 2023-07-18 Common Stock 33333 0 D This transaction relates an option that would have expired on July 18, 2023 and does not result in a reduction of shares held outright by the Reporting Person. The shares acquired upon the exercise of the option were sold pursuant to a Rule 10b5-1 stock trading plan adopted by the Reporting Person on March 24, 2023. accordingly, the Reporting Person had no discretion with regard to the timing of the transaction. This transaction was executed in multiple trades in prices ranging from $3.62 to $3.70, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The option, which was granted on July 18, 2013, and has an expiration date of July 18, 2023, is fully vested and exercisable. Chief Regulatory and Quality Affairs Officer /s/ Elizabeth Grammer, Attorney-in-Fact for Robert Blanks 2023-06-27